US EditionPublished • loading... • Updated
Leerink Partners Increases Gilead Sciences (NASDAQ:GILD) Price Target to $146.00
Summary by defenseworld.net
1 Articles
1 Articles
Leerink Partners Increases Gilead Sciences (NASDAQ:GILD) Price Target to $146.00
Gilead Sciences (NASDAQ:GILD – Get Free Report) had its target price increased by analysts at Leerink Partners from $114.00 to $146.00 in a research report issued to clients and investors on Friday,MarketScreener reports. The brokerage currently has an “outperform” rating on the biopharmaceutical company’s stock. Leerink Partners’ price objective would indicate a potential upside of 2.85% from the company’s previous close. Other equities researc…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
